Inscription Capital’s ASP Isotopes ASPI Stock Holding History

Inscription Capital’s Portfolio ASPI Stock Details ASPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,360	Closed	-$76.8K	–	724
2025 Q4	$76.8K	Buy	+14,360	New	+$114K	0.01%	669

Other funds holding ASPI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RIM

Rovida Investment Management Grand Cayman, Cayman Islands $1.47B AUM 142.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Inscription Capital's ASPI Position: Q1 2026 in Review

Inscription Capital sold out of ASP Isotopes (ASPI) in Q1 2026, closing a stake of 14,360 shares — an estimated $76.8K sold.

Inscription Capital first reported a position in ASPI in Q4 2025 and held it in 1 quarter. The position peaked at $76.8K in Q4 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

Inscription Capital reported no remaining ASP Isotopes position as of Q1 2026 after selling out during the quarter.
Inscription Capital sold 14,360 ASP Isotopes shares in Q1 2026, an estimated $76.8K.
Inscription Capital first reported a position in ASP Isotopes in Q4 2025 and held it in 1 quarter.
Inscription Capital's ASP Isotopes position peaked at $76.8K in Q4 2025.
177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.